McKesson Ventures, LLC's Form 4 filing
Augmedix, Inc. (AUGX) · filed Sep 22, 2022
- Accession no.
- 0001062993-22-019835
- Filed
- Sep 22, 2022
- Trade date
- Sep 19-21, 2022
- Filing delay
- 3 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions. Open-market sales total $14.9K. It was filed 3 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| McKesson Ventures, LLCCIK 0001827312 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 19, 2022 | Common Stock | SSaleDisposed | −3,900 | $2.18F1 | −$8,502 | 4,043,706 | Direct | |
| Sep 20, 2022 | Common Stock | SSaleDisposed | −2,500 | $2.02F2 | −$5,050 | 4,041,206 | Direct | |
| Sep 21, 2022 | Common Stock | SSaleDisposed | −720 | $1.92F3 | −$1,382.4 | 4,040,486 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $2.08 to $2.44. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F2
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.92 to $2.10. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.
- F3
The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.87 to $2.03. The Reporting Persons undertake to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Referenced by the price of 1 transaction in Table I.